Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

A Unique Factor XIII Mutation in Southeastern Iran with an Unexpectedly High Prevalence: Khash Factor XIII.

Dorgalaleh A, Tabibian S, Shams M, Majid G, Naderi M, Casini A, Tavasoli B, Gheidishiran M, Daneshi M, Safa M.

Semin Thromb Hemost. 2019 Feb;45(1):43-49. doi: 10.1055/s-0038-1676580. Epub 2019 Jan 10.

PMID:
30630205
2.

Study of the Relationship between HPA-1 and HPA-5 Gene Polymorphisms and Refractory to Platelet Therapy and Recombinant Factor VII in Glanzmann Thrombasthenia Patients in Southeast of Iran.

Naderi M, Habibpour M, Alizadeh S, Kashani Khatib Z, Dorgalaleh A, Issah MA, Naadali F.

Int J Hematol Oncol Stem Cell Res. 2018 Jan 1;12(1):43-48.

3.

Leukocyte Telomere Length Shortening, hTERT Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia

Eskandari E, Hashemi M, Naderi M, Bahari G, Safdari V, Taheri M.

Asian Pac J Cancer Prev. 2018 Jun 25;19(6):1515-1521.

4.

Long non-coding RNA PAX8-AS1 polymorphisms increase the risk of childhood acute lymphoblastic leukemia.

Bahari G, Hashemi M, Naderi M, Sadeghi-Bojd S, Taheri M.

Biomed Rep. 2018 Feb;8(2):184-190. doi: 10.3892/br.2017.1028. Epub 2017 Dec 13.

5.

Complications of Transfusion-Dependent β-Thalassemia Patients in Sistan and Baluchistan, South-East of Iran.

Yaghobi M, Miri-Moghaddam E, Majid N, Bazi A, Navidian A, Kalkali A.

Int J Hematol Oncol Stem Cell Res. 2017 Oct 1;11(4):268-272.

6.

DROSHA rs642321 Polymorphism Influence Susceptibility to Childhood Acute Lymphoblastic Leukemia: A Preliminary Report.

Hashemi M, Hasani SS, Naderi M.

Indian J Med Paediatr Oncol. 2017 Oct-Dec;38(4):416-419. doi: 10.4103/ijmpo.ijmpo_4_15.

7.

Coincidence of celiac disease with nongastrointestinal tumors in children.

Naderi M, Shahramian I, Delaramnasab M, Bazi A.

Pediatr Hematol Oncol. 2017 Nov;34(8):478-482. doi: 10.1080/08880018.2017.1404171. Epub 2017 Dec 8.

PMID:
29219666
8.

Molecular diagnosis of factor XIII deficiency, data from comprehensive coagulation laboratory in Iran.

Gheidishahran M, Dorgalaleh A, Tabibian S, Shams M, Sanei Moghaddam E, Khosravi S, Naderi M, Kahraze S, Lotfi F, Kazeme A, Safa M.

Blood Coagul Fibrinolysis. 2018 Jan;29(1):87-91. doi: 10.1097/MBC.0000000000000679.

PMID:
29095761
9.

FHIT promoter DNA methylation and expression analysis in childhood acute lymphoblastic leukemia.

Bahari G, Hashemi M, Naderi M, Sadeghi-Bojd S, Taheri M.

Oncol Lett. 2017 Oct;14(4):5034-5038. doi: 10.3892/ol.2017.6796. Epub 2017 Aug 23.

10.

Intracranial hemorrhage in congenital bleeding disorders.

Tabibian S, Motlagh H, Naderi M, Dorgalaleh A.

Blood Coagul Fibrinolysis. 2018 Jan;29(1):1-11. doi: 10.1097/MBC.0000000000000660. Review.

PMID:
28901996
11.

Xmn1-158 γGVariant in B-Thalassemia Intermediate Patients in South-East of Iran.

Miri-Moghaddam E, Bahrami S, Naderi M, Bazi A, Karimipoor M.

Int J Hematol Oncol Stem Cell Res. 2017 Apr 1;11(2):165-171.

12.

Evaluation of functional RAGE gene polymorphisms in childhood acute lymphoblastic leukemia-A case-control study from Iran.

Eskandari-Nasab E, Hashemi M, Hasani SS, Naderi M, Sadeghi-Bojd S, Taheri M.

Nucleosides Nucleotides Nucleic Acids. 2017 Mar 4;36(3):170-180. doi: 10.1080/15257770.2016.1243716. Epub 2017 Jan 3.

PMID:
28045617
13.

Association of lnc-LAMC2-1:1 rs2147578 and CASC8 rs10505477 Polymorphisms with Risk of Childhood Acute Lymphoblastic Leukemia

Hashemi M, Bahari G, Naderi M, Sadeghi Bojd S, Taheri M.

Asian Pac J Cancer Prev. 2016 Nov 1;17(11):4985-4989.

14.

Health-Related Quality of Life and Health Utility Values in Beta Thalassemia Major Patients Receiving Different Types of Iron Chelators in Iran.

Seyedifar M, Dorkoosh FA, Hamidieh AA, Naderi M, Karami H, Karimi M, Fadaiyrayeny M, Musavi M, Safaei S, Ahmadian-Attari MM, Hadjibabaie M, Cheraghali AM, Akbari Sari A.

Int J Hematol Oncol Stem Cell Res. 2016 Oct 1;10(4):224-231.

15.

Pri-miR-34b/c rs4938723 polymorphism is associated with the risk of childhood acute lymphoblastic leukemia.

Hashemi M, Bahari G, Naderi M, Sadeghi-Bojd S, Taheri M.

Cancer Genet. 2016 Nov;209(11):493-496. doi: 10.1016/j.cancergen.2016.09.009. Epub 2016 Sep 30.

PMID:
27886674
16.

Disseminated intravascular coagulation with positive D-dimer: a controversial clinical feature in severe congenital factor XIII deficiency in southeast Iran.

Naderi M, Tabibian S, Menegatti M, Kalantar E, Kazemi A, Zaker F, Dorgalaleh A.

Blood Coagul Fibrinolysis. 2016 Dec;27(8):933-935.

PMID:
26836269
17.

TET2 Promoter DNA Methylation and Expression in Childhood Acute Lymphoblastic Leukemia.

Bahari G, Hashemi M, Naderi M, Taheri M.

Asian Pac J Cancer Prev. 2016;17(8):3959-62.

18.

Cost-Effectiveness Analysis of Biogeneric Recombinant Activated Factor VII (AryoSeven™) and Activated Prothrombin Complex Concentrates (FEIBA™) to Treat Hemophilia A Patients with Inhibitors in Iran.

Golestani M, Eshghi P, Rasekh HR, Cheraghali AM, Salamzadeh J, Naderi M, Managhchi MR, Hoorfar H, Toogeh GR, Imani A, Khodayari MT, Habibpanah B, Hantooshzadeh R.

Iran J Pharm Res. 2016 Spring;15(2):669-77.

19.

Long Term Follow up Study on a Large Group of Patients with Congenital Factor XIII Deficiency Treated Prophylactically with Fibrogammin P®.

Naderi M, Karimi M, Hosseini MS, Moradi EH, Shamsizadeh M, Dorgalaleh A.

Iran J Pharm Res. 2016 Spring;15(2):635-40.

20.

Childhood acute lymphoblastic leukemia: refusal and abandonmentof treatment in the southeast of Iran.

Naderi M, Esmaeili Reykande S, Tabibian S, Alizadeh S, Dorgalaleh A, Shamsizadeh M.

Turk J Med Sci. 2016 Apr 19;46(3):706-11. doi: 10.3906/sag-1412-42.

PMID:
27513245
21.
22.

Long-term prophylaxis in patients with severe congenital factor XIII deficiency is not complicated by inhibitor formation.

Naderi M, Ahmadinejad M, Hosseini MS, Moradi E, Dorgalaleh A, Shamsizadeh M.

Blood Coagul Fibrinolysis. 2017 Jun;28(4):276-278. doi: 10.1097/MBC.0000000000000578.

PMID:
27306330
23.

Molecular Characterization of β-Thalassemia Intermedia in Southeast Iran.

Miri-Moghaddam E, Bahrami S, Naderi M, Bazi A, Karimipoor M.

Hemoglobin. 2016 Jun;40(3):173-8. doi: 10.3109/03630269.2016.1167735.

PMID:
27117567
24.

Diagnosis of factor XIII deficiency.

Dorgalaleh A, Tabibian S, Hosseini MS, Farshi Y, Roshanzamir F, Naderi M, Kazemi A, Zaker F, Aghideh AN, Shamsizadeh M.

Hematology. 2016 Aug;21(7):430-9. doi: 10.1080/10245332.2015.1101975. Epub 2016 Mar 30. Review.

PMID:
27077776
25.

Miscarriage and recurrent miscarriage in patients with congenital factor V deficiency: a report of six cases in Iran.

Naderi M, Tabibian S, Shamsizadeh M, Dorgalaleh A.

Int J Hematol. 2016 Jun;103(6):673-5. doi: 10.1007/s12185-016-1981-7. Epub 2016 Mar 15.

PMID:
26980222
26.

Marital Status and Fertility in Adult Iranian Patients with β-Thalassemia Major.

Miri-Aliabad G, Fadaee M, Khajeh A, Naderi M.

Indian J Hematol Blood Transfus. 2016 Mar;32(1):110-3. doi: 10.1007/s12288-015-0510-9. Epub 2015 Feb 7.

27.

IKZF1 gene polymorphisms increased the risk of childhood acute lymphoblastic leukemia in an Iranian population.

Bahari G, Hashemi M, Naderi M, Taheri M.

Tumour Biol. 2016 Jul;37(7):9579-86. doi: 10.1007/s13277-016-4853-0. Epub 2016 Jan 21.

PMID:
26790447
28.

Establishment of a prenatal diagnosis schedule as part of a prophylaxis program of factor XIII deficiency in the southeast of Iran.

Naderi M, Reykande SE, Dorgalaleh A, Alizadeh S, Tabibian S, Einollahi N, Moghaddam EM.

Blood Coagul Fibrinolysis. 2016 Jan;27(1):97-100. doi: 10.1097/MBC.0000000000000374. Erratum in: Blood Coagul Fibrinolysis. 2016 Mar;27(2):234.

PMID:
26703985
29.

Morbidity and mortality in a large number of Iranian patients with severe congenital factor XIII deficiency.

Dorgalaleh A, Naderi M, Shamsizadeh M.

Ann Hematol. 2016 Feb;95(3):451-5. doi: 10.1007/s00277-015-2568-8. Epub 2015 Dec 22. Review.

PMID:
26692088
30.

First cases of severe congenital factor XIII deficiency in Southwestern Afghanistan in the vicinity of southeast of Iran.

Hosseini S, Dorgalaleh A, Bamedi T, Tavakol K, Tabibian S, Naderi M, Alizadeh S, Varmaghani B, Shamsizadeh M, Rahimizadeh A, Ebrahimi S.

Blood Coagul Fibrinolysis. 2015 Dec;26(8):908-11. doi: 10.1097/MBC.0000000000000358.

PMID:
26226252
31.

Effect of Social Factors on the Highest Global Incidence of Congenital Factor XIII Deficiency in Southeast of Iran.

Naderi M, Alizadeh S, Tabibian S, Hosseini S, Varmaghani B, Shamsizadeh M, Dorgalaleh A.

Arch Iran Med. 2015 May;18(5):331. No abstract available.

PMID:
26155604
32.

Evaluation of rs3102735 and rs2073617 Osteoprotegerin Gene Polymorphisms and the Risk of Childhood Acute lymphoblastic Leukemia in Zahedan Southeast Iran.

Hashemi M, Ebrahimi M, Amininia S, Naderi M, Eskandari-Nasab E, Taheri M.

Int J Hematol Oncol Stem Cell Res. 2014 Oct 1;8(4):39-44.

33.

Factor XIII deficiency in Iran: a comprehensive review of the literature.

Dorgalaleh A, Naderi M, Hosseini MS, Alizadeh S, Hosseini S, Tabibian S, Eshghi P.

Semin Thromb Hemost. 2015 Apr;41(3):323-9. doi: 10.1055/s-0034-1395350. Epub 2015 Jan 23. Review.

PMID:
25615432
34.

Association between expression of MMP-2 and MMP-9 genes and pathogenesis of intracranial hemorrhage in severe coagulation factor XIII deficiency.

Naderi M, Younesi MR, Dorgalaleh A, Alizadeh S, Kazemi A, Tabibian S.

Hematology. 2015 Sep;20(8):487-492. doi: 10.1179/1607845414Y.0000000226. Epub 2014 Dec 29.

PMID:
25544259
35.

Protecting metal-organic framework crystals from hydrolytic degradation by spray-dry encapsulating them into polystyrene microspheres.

Carné-Sánchez A, Stylianou KC, Carbonell C, Naderi M, Imaz I, Maspoch D.

Adv Mater. 2015 Feb 4;27(5):869-73. doi: 10.1002/adma.201403827. Epub 2014 Dec 10.

36.

Congenital factor V deficiency: comparison of the severity of clinical presentations among patients with rare bleeding disorders.

Naderi M, Tabibian S, Alizadeh S, Hosseini S, Zaker F, Bamedi T, Shamsizadeh M, Dorgalaleh A.

Acta Haematol. 2015;133(2):148-54. doi: 10.1159/000363598. Epub 2014 Sep 26.

PMID:
25277779
37.

Public Health Problems related to factor V deficiency in southeast of Iran.

Naderi M, Tabibian S, Dorgalaleh A, Kashani Kahtib Z, Alizadeh S.

Med J Islam Repub Iran. 2014 May 7;28:27. eCollection 2014. No abstract available.

38.

Clinical manifestations and management of life-threatening bleeding in the largest group of patients with severe factor XIII deficiency.

Naderi M, Dorgalaleh A, Alizadeh S, Tabibian S, Hosseini S, Shamsizadeh M, Bamedi T.

Int J Hematol. 2014 Nov;100(5):443-9. doi: 10.1007/s12185-014-1664-1. Epub 2014 Sep 18.

PMID:
25230816
39.

Congenital combined deficiency of coagulation factors: a study of seven patients.

Naderi M, Tabibian S, Hosseini MS, Alizadeh S, Hosseini S, Shamsizadeh M, Dorgalaleh A.

Blood Coagul Fibrinolysis. 2015 Jan;26(1):59-62. doi: 10.1097/MBC.0000000000000180.

PMID:
25215615
40.

Association of functional polymorphism at the miR-502-binding site in the 3' untranslated region of the SETD8 gene with risk of childhood acute lymphoblastic leukemia, a preliminary report.

Hashemi M, Sheybani-Nasab M, Naderi M, Roodbari F, Taheri M.

Tumour Biol. 2014 Oct;35(10):10375-9. doi: 10.1007/s13277-014-2359-1. Epub 2014 Jul 23.

PMID:
25048968
41.

Central nervous system bleeding in pediatric patients with factor XIII deficiency: a study on 23 new cases.

Naderi M, Alizadeh S, Kazemi A, Tabibian S, Zaker F, Bamedi T, Kashani Khatib Z, Dorgalaleh A.

Hematology. 2015 Mar;20(2):112-8. doi: 10.1179/1607845414Y.0000000172. Epub 2014 Jul 7.

PMID:
25001244
42.

Intracranial hemorrhage pattern in the patients with factor XIII deficiency.

Naderi M, Zarei T, Haghpanah S, Eshghi P, Miri-Moghaddam E, Karimi M.

Ann Hematol. 2014 Apr;93(4):693-7. doi: 10.1007/s00277-013-1918-7. Epub 2013 Oct 23.

PMID:
24149912
43.

A prospective study of tubular dysfunction in pediatric patients with Beta thalassemia major receiving deferasirox.

Naderi M, Sadeghi-Bojd S, Valeshabad AK, Jahantigh A, Alizadeh S, Dorgalaleh A, Tabibian S, Bamedi T.

Pediatr Hematol Oncol. 2013 Nov;30(8):748-54. doi: 10.3109/08880018.2013.823470.

PMID:
24134694
44.

A functional polymorphism in the miR-146a gene is associated with the risk of childhood acute lymphoblastic leukemia: a preliminary report.

Hasani SS, Hashemi M, Eskandari-Nasab E, Naderi M, Omrani M, Sheybani-Nasab M.

Tumour Biol. 2014 Jan;35(1):219-25. doi: 10.1007/s13277-013-1027-1. Epub 2013 Jul 27.

PMID:
23888320
45.

A note on the security of IS-RFID, an inpatient medication safety.

Safkhani M, Bagheri N, Naderi M.

Int J Med Inform. 2014 Jan;83(1):82-5. doi: 10.1016/j.ijmedinf.2013.04.003. Epub 2013 May 7.

PMID:
23659961
46.

Post-traumatic stress disorder and related factors in parents of children with cancer in South-East of iran.

Naderi M, Firouzkoohi Moghadam M, Hamzenejad M, Emamdadi A, Karami H.

Iran Red Crescent Med J. 2012 Dec;14(12):776-81. doi: 10.5812/ircmj.2163. Epub 2012 Dec 6.

47.

The crystal engineering of salbutamol sulphate via simulated pulmonary surfactant monolayers.

Davies MJ, Kerry TD, Seton L, Murphy MF, Gibbons P, Khoo J, Naderi M.

Int J Pharm. 2013 Mar 25;446(1-2):34-45. doi: 10.1016/j.ijpharm.2013.01.044. Epub 2013 Feb 4.

PMID:
23391511
48.

Evaluation of Mental Health and Related Factors among Patients with Beta-thalassemia Major in South East of Iran.

Naderi M, Hormozi MR, Ashrafi M, Emamdadi A.

Iran J Psychiatry. 2012 Winter;7(1):47-51.

49.

On the designing of a tamper resistant prescription RFID access control system.

Safkhani M, Bagheri N, Naderi M.

J Med Syst. 2012 Dec;36(6):3995-4004. doi: 10.1007/s10916-012-9872-9. Epub 2012 Aug 10.

PMID:
22878923
50.

Effect of milling on particle shape and surface energy heterogeneity of needle-shaped crystals.

Ho R, Naderi M, Heng JY, Williams DR, Thielmann F, Bouza P, Keith AR, Thiele G, Burnett DJ.

Pharm Res. 2012 Oct;29(10):2806-16. doi: 10.1007/s11095-012-0842-1. Epub 2012 Aug 8.

PMID:
22872437

Supplemental Content

Loading ...
Support Center